SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

INOs FDA approval is prompting traders to speculate that the agency may be more receptive to rare-disease treatments, lifting attention on Capricor ahead of deramiocels FDA decision for Duchenne muscular dystrophy. The community is divided: some see the approval, recent data and launch-related hiring as encouraging signals, while others stress that CAPRs outcome is uncertain given prior FDA concerns and debate over the evidence.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has put Precigens PAPZIMEOS in focus, prompting debate over the threat of new competition. Some traders worry about market share, while others argue Precigens first-mover advantage, commercial launch, and full approval temper the risk compared with Inovios accelerated approval.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could decline significantly during 2027 has fueled a sharp selloff, raising concerns about pricing and CorMedixs largest revenue driver. Traders disagree over whether DaVitas preliminary outlook signals lasting pressure, pointing to CMSs more reassuring payment estimate and arguing the reaction may be excessive.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected quarterly report, fueled by demand for Mounjaro and Zepbound and a higher full-year revenue outlook, is driving LLYs rally and analyst upgrades. Bullish traders point to continued obesity-drug growth, while skeptics flag the trimmed profit outlook and high valuation.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is under pressure in a sharp semiconductor selloff as traders question whether heavy AI infrastructure spending will deliver sufficient returns, with weak Intel guidance and Amazons elevated capital spending adding to tech-sector jitters. The community is divided between warnings that AI-related investment and financing risks could prolong the decline and dip buyers pointing to strong demand and oversold conditions.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Robloxs quarterly results beat estimates, but declining user activity and a forecast for lower fourth-quarter bookings have driven a sharp selloff. Traders are largely bearish over slowing growth and monetization, while some view the drop as an overreaction and a buying opportunity.

BitGo Holdings, Inc. operates as a digital asset infrastructure company delivering custody, wallets, staking, trading, financing, stablecoins, and settlement services from regulated cold storage. It focuses on accelerating the transition of the financial system to a digital asset economy. The company was founded by Michael Belshe and Ben Davenport in 2013 and is headquartered in Sioux Falls, SD.

BitGo Holdings Inc. - Ordinary Shares - Class A

BTGOs steep selloff and disappointing earnings are driving debate, with traders pointing to losses and weak share-price performance even as revenue and crypto-infrastructure activity grow. Bullish holders see potential in a Bitcoin recovery and expanding institutional custody business, while bears question the companys profitability and its failure to keep pace with other crypto stocks.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is drawing attention after a sharp selloff tied to Brazils election results and broader weakness in Brazilian-linked stocks. Traders disagree over whether political and market risks signal further downside or create a buying opportunity, with some pointing to the companys continued growth ahead of earnings.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas stronger-than-expected quarterly results and cost-savings plan to support drug development are driving attention, alongside CEO optimism about its pipeline. Traders are reacting to the sharp rise and move above the 200-day average with broadly bullish commentary.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas earnings beat and raised outlook, alongside its positioning as an identity-security layer for AI agents, have fueled a sharp cybersecurity-led rally. Traders are divided over whether demand can justify the valuation, with some taking profits or betting on a pullback after the run-up.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wiley Accelerates Growth of World-Renowned Advanced Portfolio with Four New Research Journal Launches

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of four additional new journals in its prestigious Advanced Portfolio, one of the worlds top-tier research journal series. Advanced City, Advanced Food, Advanced Microbiome, and...

John Wiley & Sons (WLY) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes? Let's find out.

Wiley Announces Quarterly Dividend; Leader in Trusted Content and Research Intelligence Raised Dividend for 33rd Consecutive Year in June 2026

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that its Board of Directors has declared a quarterly cash dividend of $0.3575 per share on its Class A and Class B Common...

John Wiley & Sons (WLY) Beats Q1 Earnings and Revenue Estimates

John Wiley & Sons (WLY) delivered earnings and revenue surprises of +10.00% and +1.62%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Wiley Reports First Quarter 2027 Results; Q1 in Line With Expectations and Full Year Outlook Reaffirmed

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the first quarter ended July 31, 2026. First Quarter Summary GAAP performance vs. prior year: Revenue of $386...

Wiley Schedules First Quarter Fiscal 2027 Earnings Release and Conference Call

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its first quarter fiscal 2027 results prior to market open on Thursday, September 3, 2026. The Company has scheduled a conference...

Wiley Launches Its First Spectral Analysis API Portfolio, Giving Labs a Faster Path from Unknown Substance to Validated Answer

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of its spectral analysis application programming interface (API) portfolio, providing users with a new, faster way to access its trusted spectral data, analytical algorithms, and...

4 Must-Buy Consumer Staples Stocks as Consumer Sentiment Dips

COCO, DAR, WLY and ADM stand out as defensive consumer staples stocks as sentiment dampens and economic uncertainty persists.

4 Consumer Staples Stocks to Play Safe Amid Sinking Consumer Confidence

COCO, KO, WLY and CSV stand out as defensive consumer staples picks since weak consumer confidence and market volatility fuel demand for safer stocks.

John Wiley & Sons, Inc. engages in the provision of research and learning materials. It operates through the following segments: Research, Learning, and Held for Sale or Sold. The Research segment consists of research publishing and research solutions. The Learning segment includes academic and professional reporting lines and consists of publishing and related knowledge solutions. The Held for Sale or Sold segment offers businesses held-for-sale including Wiley Edge and CrossKnowledge, University Services and Tuition Manager, and Test Prep and Advancement Courses. The company was founded by Charles Wiley in 1807 and is headquartered in Hoboken, NJ.

John Wiley & Sons Inc. - Ordinary Shares - Class A

INFQ Stock Surges After Three DOE Awards In $5B Genesis Mission – HPE, WLY Also Gain On Joining Federal AI Initiative

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>HPE advanced after announcing participation in multiple AI and scientific computing projects, including development of the Lux AI supercomputing platform.</li><li>Wiley joined the Genesis Mission Consortium, becoming the only scientific publisher participating alongside companies such as Nvidia, Microsoft, AMD, IBM, and AWS.</li><li>The Trump administration expanded the Department of Energy's Genesis Mission to more than $5 billion in federal commitments earlier in the day.</li></ul>Shares of Infleqtion (INFQ), Hewlett Packard Enterprise (HPE), and Wiley (WLY) climbed in midday trade on Wednesday after each company announced new roles in the Department of Energy's Genesis Mission, following the Trump administration's expansion of the initiative to more than $5 billion in federal commitments.The&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-5b-genesis-mission-ai-initiative-targeting-cancer-chips-quantum-computing/cZZm1gVR7DG">Genesis Mission</a> brings together more than 15 federal agencies to accelerate advances in artificial intelligence, quantum computing, semiconductor research, and scientific discovery by combining research funding, scientific datasets, supercomputing resources, and AI infrastructure.Among the three companies,&nbsp;<a href="https://stocktwits.com/symbol/INFQ">INFQ’s stock</a> posted the strongest gains, with shares rising more than 8% in midday trade.&nbsp;<a href="https://stocktwits.com/symbol/HPE">HPE’s stock</a> rose nearly 5%, while&nbsp;<a href="https://stocktwits.com/symbol/WLY">WLY’s stock</a> gained more than 1%. INFQ's stock was also among top trending tickers on Stocktwits at the time of writing. Retail sentiment around the company remained in ‘bullish’ territory over the past day and platform data showed&nbsp;an uptick of around 25% in message volume.While INFQ stock led gains among the three on Wednesday, it has underperformed WLY and HPE over the past year.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260722_123116876_png_4fb37bb5bc.webp" alt="koyfin_20260722_123116876.png" width="2400" height="1240"><figcaption>INFQ, HPE, WLY stocks performance year-to-date. | Source: Koyfin</figcaption></figure><h2 class="st-heading-2">Infleqtion Wins Three Quantum Projects</h2>Infleqtion, which develops neutral-atom quantum computing and quantum sensing technology, received three Department of Energy research projects under the Genesis Mission.&nbsp;The first was for work on an AI-optimized quantum circuit design for nuclear applications in collaboration with Argonne National Laboratory. The second centered&nbsp;on deployable atomic quantum sensing enabled by agentic AI&nbsp;in partnership with Brookhaven National Laboratory. The third award focused on quantum machine learning research for nuclear fusion simulations with Lawrence Livermore National Laboratory and the University of Colorado Boulder.<blockquote>"AI data centers are pulling more power than the grid was ever built to handle, and the industry is recognizing that these types of issues are beyond the capabilities of classical computing alone."– Matthew Kinsella, Chief Executive Officer, Infleqtion</blockquote>Infleqtion also announced plans on Wednesday to deploy a fault-tolerant neutral-atom quantum computer at the Illinois Quantum &amp; Microelectronics Park in 2027, alongside a new Chicago Quantum Innovation Center focused on energy-grid applications.<h2 class="st-heading-2">HPE And Wiley Expand Their Federal AI Footprint</h2>HPE was selected for multiple research and development projects spanning AI applications, networking, cybersecurity, scientific workflow optimization, and water resource forecasting.The company said it was also developing Lux, which it expects will become the first dedicated AI system for science supporting the Genesis Mission. The system is being developed alongside Advanced Micro Devices (AMD) and Oak Ridge National Laboratory.Meanwhile, Wiley joined the Genesis Mission Consortium, becoming the initiative's only scientific publisher. The consortium also includes Nvidia (NVDA), Amazon Web Services (AWS), Microsoft (MSFT), IBM (IBM), and AMD.&nbsp;Retail sentiment around HPE’s stock on Stocktwits around the company remained in ‘bearish’ territory over the past day, while sentiment around WLY’s stock stayed in ‘neutral’ territory over the past day.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/gev-stock-ge-vernova-q2-earnings-miss-data-center-guidance-raise/cZZmiCVR7wx">GEV Stock Drops On Q2 Earnings Miss – CEO Raises Guidance, Says Data Center Orders Have Already Doubled 2025 Total</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Infleqtion logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Shares of Infleqtion (INFQ), Hewlett Packard Enterprise (HPE), and Wiley (WLY) climbed in midday trade on Wednesday after each company announced new roles in the Department of Energy's Genesis Mission

INFQ, HPE, WLY Stocks Rise On Trump Administration’s $5B Genesis Mission Expansion

Infleqtion received three Department of Energy research projects and led gains among the companies tied to the initiative.


Hewlett Packard Enterprise Co

Infleqtion Inc.

Defiance Quantum ETF

Technology Select Sector SPDR Fund

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$51.17
Prev Close	$51.44
Open	$50.98
Dividend Yield	3.47%
50-Day Moving Average	$50.36
Beta	0.57
Avg. Volume	608,025.04
PE Ratio	13.61

52-Week High	$57.45
52-Week Low	$28.38
Market Capitalization	$2.61B
EPS (Annual)	$4.16
Price to Book	3.27
Revenue Per Employee	$372,561.78

Feed

News

Sentiment

Earnings

Fundamentals

Info

WLY Fundamentals